Abstract: The invention relates to the composition, preparation and use of a formulation as an adjuvant for human or animal use, said formulation comprising at least one bile acid or salts thereof and saponin, in order to enhance the immune response against an antigen, which may or may not be well defined, including but not limited to bacterins, antigens and antigenic preparations that are viral, bacterial or parasitic, and antigens associated with diseases such as different types of cancer. The antigens used can be isolated from pathogens, as well as products resulting from enzymatic or chemical modification, synthetic or recombinant antigens, or mixtures of the same.
Type:
Application
Filed:
December 9, 2013
Publication date:
November 5, 2015
Applicant:
UNIVERSIDAD DE LA REPUBLICA DE URUGUAY
Inventors:
Fernando Amaury FERREIRA CHIESA, Leonora QUIRICI VALADAN, Maria Ines BESSIO PRATO, Luis Fernando SILVEIRA GONZALEZ
Abstract: Compounds derived from imidazo[4,5-c][1,2,6]thiadiazine 2,2-dioxides, for use as a drug or pharmaceutical composition for treatment of parasitic diseases, preferably of diseases caused by parasites of the Trypanosoma genus, and more preferably for treatment of the Chagas disease. Furthermore, the invention also relates to the pharmaceutical compositions comprising said compounds.
Type:
Grant
Filed:
January 26, 2010
Date of Patent:
August 26, 2014
Assignees:
Universidad de la Republica de Uruguay, Consejo Superior de Investigaciones Cientificas
Inventors:
Juan Antonio Paez Prosper, Nuria Eugenia Campillo Martín, Ángela Guerra Álvarez, Maria Mercedes González Hormaizteguy, Hugo Cerecetto Meyer